Commercialization of Generics Impacts Adverse Event Rates

Share this content:
Commercialization of Generics Impacts Adverse Event Rates
Commercialization of Generics Impacts Adverse Event Rates

WEDNESDAY, Oct. 4, 2017 (HealthDay News) -- Immediate or delayed differences in adverse event rates were seen after generic commercialization of three antihypertensive drugs, according to a study published online Oct. 3 in Circulation: Cardiovascular Quality and Outcomes.

Jacinthe Leclerc, R.N., from the Institut National de Santé Publique du Québec in Canada, and colleagues examined the impact of three generic angiotensin II receptor blockers' commercialization on adverse events for 136,177 losartan, valsartan, and candesartan users (age ≥66 years). Rates of adverse events were calculated monthly, 24 months before, and 12 months after generic commercialization.

The researchers found that before and after generic commercialization, for all users, there was a monthly mean rate of 100 adverse events for 1,000 angiotensin II receptor blockers users. The month of generic commercialization, there was an increase in the rates of adverse events among generic users of losartan, valsartan, and candesartan of 8, 11.7, and 14 percent, respectively (difference of proportions versus brand name, 7.5 [95 percent confidence interval, -0.9 to 15.9 percent], 17.1 [95 percent confidence interval, 9.9 to 24.3 percent], and 16.6 percent [95 percent confidence interval, 7.9 to 25.3 percent], respectively). At ≤one year after generic commercialization, the monthly trend of adverse events was affected for generic versus brand-name losartan users only (difference of proportions, 2 percent). Results were similar in sensitivity analyses.

"Risk and survival analysis studies controlling for several potential confounding factors are required to better characterize generic substitution," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Medicare Requiring Hospitals to Post Prices Online

Medicare Requiring Hospitals to Post Prices Online

Medicare would base part of a hospital's payments on how easy it is for patients to access medical records

Restless Brain Syndrome Tied to Changes in the Brain

Restless Brain Syndrome Tied to Changes in the ...

Morphological differences seen in the primary somatosensory system

People With Opioid Use Disorder Have High Suicide Rate

People With Opioid Use Disorder Have High Suicide ...

Based on data from multiple sources, many opioid-overdose deaths seem to be suicides

is free, fast, and customized just for you!

Already a member?

Sign In Now »